Literature DB >> 12899871

Beyond LGMD1A: myotilin is a component of central core lesions and nemaline rods.

R Schröder1, J Reimann, P Salmikangas, C S Clemen, Y K Hayashi, I Nonaka, K Arahata, O Carpén.   

Abstract

Myotilin is a Z-disc protein that binds alpha-actinin, gamma-filamin and F-actin. The essential role of myotilin in skeletal muscle is highlighted by the recent observation that autosomal dominant limb girdle muscular dystrophy type 1A is caused by mutations in the human myotilin gene. We studied the expression and subcellular distribution of myotilin in nemaline myopathy, central core disease, centronuclear myopathy, and myopathies with tubular aggregates. A prominent myotilin immunostaining of nemaline rods and core lesions was detected in all ten cases of nemaline myopathy and five cases of central core disease. This renders myotilin a sensitive, though non-specific marker for these structural lesions. Western blot analysis did not indicate an increased myotilin expression in nemaline myopathy muscle. However, the analysis indicated upregulation of a 75 kDa immunoreactive band, very weak in control muscle but previously detected in limb girdle muscular dystrophy 1A samples. Our findings indicate that myotilin is a core structural molecule in nemaline rods and central core lesions and suggest modification of myotilin in nemaline myopathy, and further support the notion that myotilin may have a key role in the dynamic molecular events mediating myofibril assembly in normal and diseased human skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12899871     DOI: 10.1016/s0960-8966(03)00064-6

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

1.  New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients.

Authors:  Daniela Piga; Francesca Magri; Dario Ronchi; Stefania Corti; Denise Cassandrini; Eugenio Mercuri; Giorgio Tasca; Enrico Bertini; Fabiana Fattori; Antonio Toscano; Sonia Messina; Isabella Moroni; Marina Mora; Maurizio Moggio; Irene Colombo; Teresa Giugliano; Marika Pane; Chiara Fiorillo; Adele D'Amico; Claudio Bruno; Vincenzo Nigro; Nereo Bresolin; Giacomo Pietro Comi
Journal:  J Mol Neurosci       Date:  2016-04-22       Impact factor: 3.444

2.  Nemaline myopathy type 6: clinical and myopathological features.

Authors:  Montse Olivé; Lev G Goldfarb; Hee-Suk Lee; Zagaa Odgerel; Andre Blokhin; Laura Gonzalez-Mera; Dolores Moreno; Nigel G Laing; Nyamkhishig Sambuughin
Journal:  Muscle Nerve       Date:  2010-12       Impact factor: 3.217

3.  Differences in gene expression between strabismic and normal human extraocular muscles.

Authors:  Amy L Altick; Cheng-Yuan Feng; Karen Schlauch; L Alan Johnson; Christopher S von Bartheld
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-03       Impact factor: 4.799

4.  Cullin-3 dependent deregulation of ACTN1 represents a new pathogenic mechanism in nemaline myopathy.

Authors:  Jordan Blondelle; Kavya Tallapaka; Jane T Seto; Majid Ghassemian; Madison Clark; Jenni M Laitila; Adam Bournazos; Jeffrey D Singer; Stephan Lange
Journal:  JCI Insight       Date:  2019-04-16

Review 5.  Thin filament proteins mutations associated with skeletal myopathies: defective regulation of muscle contraction.

Authors:  Julien Ochala
Journal:  J Mol Med (Berl)       Date:  2008-06-24       Impact factor: 4.599

Review 6.  Pathological defects in congenital myopathies.

Authors:  Caroline A Sewry
Journal:  J Muscle Res Cell Motil       Date:  2008-12-30       Impact factor: 2.698

7.  Actin nemaline myopathy mouse reproduces disease, suggests other actin disease phenotypes and provides cautionary note on muscle transgene expression.

Authors:  Gianina Ravenscroft; Connie Jackaman; Caroline A Sewry; Elyshia McNamara; Sarah E Squire; Allyson C Potter; John Papadimitriou; Lisa M Griffiths; Anthony J Bakker; Kay E Davies; Nigel G Laing; Kristen J Nowak
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

8.  RNAi-mediated Gene Silencing of Mutant Myotilin Improves Myopathy in LGMD1A Mice.

Authors:  Jian Liu; Lindsay M Wallace; Sara E Garwick-Coppens; Darcée D Sloboda; Carol S Davis; Chady H Hakim; Michael A Hauser; Susan V Brooks; Jerry R Mendell; Scott Q Harper
Journal:  Mol Ther Nucleic Acids       Date:  2014-04-29       Impact factor: 10.183

9.  Core myopathies - a short review.

Authors:  Haluk Topaloglu
Journal:  Acta Myol       Date:  2020-12-01

Review 10.  The vertebrate muscle Z-disc: sarcomere anchor for structure and signalling.

Authors:  Pradeep K Luther
Journal:  J Muscle Res Cell Motil       Date:  2009-10-15       Impact factor: 2.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.